MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.

By Shuai Jiang, Hong-Wei Zhang, Ming-hua Lu, Xiao-Hong He, Yong Li, Hua Gu, Mo-Fang Liu, E. Wang. Cancer Research, 2010

703 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/1bc7389ed9a9e0422e2e512a24540a0a22d994d7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. D. Rao
2. David Baltimore
3. Ryan M. O’Connell
4. Aadel A Chaudhuri
5. David P. Bartel

In Molecular Biology

1. David Baltimore
2. Ryan M. O’Connell
3. D. Rao
4. Aadel A Chaudhuri
5. June L. Round
6. S. Mazmanian
7. David P. Bartel
8. A. Klug

In Oncology

1. June L. Round

Citations in the corpus

• MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development (2010, background): “…studies found that miR-155 targets Sma- and Mad-related protein 5 (Smad5) in B cell lymphoma cells (Rai et al., 2010) and activates signal trans- ducer and activator of transcription 3 (Stat3) in breast cancer cells (Jiang et al., 2010), factors involved in TGF-b and IL-6 signaling, respectively.”